Topical ketorolac tromethamine , @ % , significantly lowered aqueous IL-@ levels and vitreous IL-@ and PDGF-AA levels in this series of eyes , suggesting that it may cause meaningful inhibition of inflammatory cytokines implicated in the pathogenesis of DR.